Clinical Trial Update: Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC) [NA]

View source ↗

Summary

A clinical trial investigating whether MRI can predict outcomes in pancreatic ductal adenocarcinoma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: PDAC - Pancreatic Ductal Adenocarcinoma | NA | Status: SUSPENDED